LivaNova (LIVN) Cash from Restructuring (2016 - 2020)
LivaNova (LIVN) reported Cash from Restructuring of -$277000.0 for Q3 2020, up 78.58% on a YoY basis from -$155115.2 in Q4 2019, and up 41.56% sequentially from -$474000.0 in Q2 2020.
LivaNova (LIVN) Cash from Restructuring (2016 - 2020) Analysis & Trends
LivaNova (LIVN) has 5 years of Cash from Restructuring data on file, last reported at -$277000.0 in Q3 2020.
- For the quarter ending Q3 2020, Cash from Restructuring rose 78.58% year-over-year to -$277000.0; the trailing twelve-month figure through Sep 2020 stood at -$1.2 million (down 86.51% YoY), and the FY2019 full-year result was -$6.7 million, down 203.74% from the prior year.
- Cash from Restructuring improved to -$277000.0 in Q3 2020, from -$474000.0 in the prior quarter.
- In the past five years, Cash from Restructuring ranged from a high of $22.0 million in Q1 2016 to a low of -$6.7 million in Q1 2017.
- A 5-year average of $89944.4 and a median of -$594000.0 in 2018 frame the typical range for Cash from Restructuring.
- Across the five-year window, Cash from Restructuring soared 440.13% in 2018 and plunged 1639.29% in 2019, its largest moves.
- Tracing LIVN's Cash from Restructuring over 5 years: stood at -$2.6 million in 2016, then advanced by 29.42% to -$1.8 million in 2017, then soared by 440.13% to $6.1 million in 2018, then tumbled by 99.69% to $19000.0 in 2019, then tumbled by 1557.89% to -$277000.0 in 2020.
- Business Quant data shows LIVN's Cash from Restructuring at -$277000.0 in Q3 2020, -$474000.0 in Q2 2020, and -$443000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -277,000.00 |
| Jun 30, 2020 | -474,000.00 |
| Mar 31, 2020 | -443,000.00 |
| Dec 31, 2019 | 19,000.00 |
| Sep 30, 2019 | -1.29 Mn |
| Jun 30, 2019 | -567,000.00 |
| Mar 31, 2019 | -4.91 Mn |
| Dec 31, 2018 | 6.14 Mn |
| Sep 30, 2018 | 84,000.00 |
| Jun 30, 2018 | -621,000.00 |
| Mar 31, 2018 | 905,000.00 |
| Dec 31, 2017 | -1.80 Mn |
| Sep 30, 2017 | -1.62 Mn |
| Jun 30, 2017 | -4.43 Mn |
| Mar 31, 2017 | -6.70 Mn |
| Dec 31, 2016 | -2.56 Mn |
| Sep 30, 2016 | -1.84 Mn |
| Mar 31, 2016 | 22.01 Mn |